Multiple sclerosis: Why do we understand so little and are unable to provide meaningful therapy?

Israel Steiner, Puiu Nisipeanu, Itzhak Wirguin

Research output: Contribution to journalReview articlepeer-review

Abstract

Objectives: Despite many years of intensive research, multiple sclerosis (MS) still evades understanding and its treatment remains suboptimal. Our aim in this report is to analyze the reasons for this situation, review the present available therapies and put forward several constructive suggestions. Methodology: We searched the literature from 1966 to 2005 for relevant articles and chapters. Review articles were also included. Results: Reasons for the current satelment in the field are the meaninglessly broad spectrum of diagnostic criteria, the inability to define the efficacy of therapies, lack of fulfillment of criteria for an autoimmune condition and the pressure from the biomedical industry. Conclusions: Clinical criteria for diagnosis should be redefined and the new set of disease classification should be based on disease course; clinical studies should consist of homogenous group of patients and a uniform set of end points to evaluate clinical therapeutic trials should be agreed upon. Most important, a moratorium on the autoimmunity hypothesis in MS will enable to redirect funds for research with lower emphasis on autoimmunity, but rather on novel approaches to the problem.

Original languageEnglish
Pages (from-to)90-94
Number of pages5
JournalInternational Journal of Neuroprotection and Neuroregeneration
Volume2
Issue number2
StatePublished - Feb 2006
Externally publishedYes

Keywords

  • Autoimmunity
  • Experimental allergic encephalomyelitis
  • Multiple sclerosis
  • Nervous system

Fingerprint

Dive into the research topics of 'Multiple sclerosis: Why do we understand so little and are unable to provide meaningful therapy?'. Together they form a unique fingerprint.

Cite this